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ABSTRACT 
 
Kristin D. Dillow: Physician evaluation among dental patients who screen high-risk for  
sleep apnea. 
 (Under the direction of Gregory K. Essick) 
 
 
This study sought to investigate the feasibility of screening for obstructive sleep apnea 
(OSA) risk in a dental practice and to examine patient response to a recommendation for 
physician evaluation.  OSA risk was assessed for 119 adults using the validated STOP 
screening questionnaire and overnight pulse oximetry.  Patients classified as high-risk on one 
or both instruments were advised to seek physician evaluation.  Fifty percent (50.4%) of 
patients screened high-risk on STOP questions, 58% on pulse oximetry, and 31.9% on both 
instruments.  Follow-up information obtained from 111 patients (93.3%) revealed that 42 
patients (35.3%) sought physician evaluation within three months of OSA screening.  
Probability of care seeking was similar for patients at high-risk by simple questions or pulse 
oximetry when instruments were jointly administered.  Findings have implications for the 
establishment of recommendations for clinically based OSA screening. 
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1.  INTRODUCTION 
 Obstructive sleep apnea (OSA) is increasing in prevalence, widely undiagnosed, 
and a precursor of significant pathology.  Marked by a lapse in breathing or a significant 
reduction of airflow during sleep, moderate OSA is estimated to affect 10% of men and 
3% of women aged 30-49 years and 17% and 9% of men and women, respectively, aged 
50-70 years.
1 
Additionally, more than 80% of moderate to severe OSA cases remain 
undiagnosed.
2,3
 The percentage of OSA among American adults is steadily increasing with 
the rising rate of obesity.  Young et al. found that obesity is the strongest contributing 
factor to OSA, which strengthens the assumption that the increasing prevalence of OSA 
parallels that of obesity.
4
 OSA is the leading cause of excessive daytime sleepiness and is 
associated with the development of hypertension,
5
 cardiovascular disease,
6
 metabolic 
syndrome,
7
 stroke,
8
 and depression.
9
 When left untreated, OSA is a significant medical 
condition that can impair quality of life.   
At present, polysomnography (PSG) provides formal diagnosis of sleep apnea; 
however, insufficient numbers of sleep laboratories and the prohibitive cost of their 
services may discourage this type of evaluation.
10
 As disease awareness increases, so does 
the demand for convenient and economical methods of diagnosing patients with OSA and 
of screening individuals to identify those at risk for OSA.       
 To assess a possible need for PSG, questionnaires such as the STOP, STOP-Bang, 
and Epworth Sleepiness Scale (ESS) are becoming widely accepted for their use in 
screening for OSA risk in clinical settings.  Specifically, the STOP and STOP-Bang 
 2 
questionnaires have been shown to have the highest methodological validity, reasonable 
accuracy, and simplicity.
10
 Likewise, home sleep testing devices measuring pulse oximetry 
provide objective data and often comparable diagnostic outcomes as those yielded with 
conventional PSG, particularly for patients with more severe disease.
11-13
   
 As with many systemic diseases, OSA may have an association with periodontitis.  
Ahmad et al. found that dental patients who screened high-risk for OSA were four times 
more likely to have moderate or severe periodontitis than those who screened low-risk 
(95% CI: 1.5, 11.4).
14
 Similarly, a study conducted by Gunaratnam et al. suggests that the 
prevalence of periodontitis is greater in patients with OSA.
15
 The high prevalence of 
undiagnosed sleep apnea and its potential relationship with chronic periodontitis suggest 
that dentists and dental hygienists could provide a valuable service to patients by 
incorporating sleep apnea screening into their practice.
16
 This is especially important for 
dental patients who do not regularly access general health care.  An estimated 23% of 
adults who visit their dentist regularly do not have contact with a physician.
17
 By 
incorporating OSA screening into clinical practice, dentists and dental hygienists can alert 
patients about the need for follow-up with a physician, when warranted.  Therefore, the 
aim of this study was to investigate the feasibility of screening for OSA risk in a dental 
practice and to examine the response of patients to a recommendation for physician 
evaluation. 
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2.  REVIEW OF THE LITERATURE 
2.1 Classifications of Sleep Apnea 
 Sleep apnea is defined by events of complete cessation of breathing (apnea) or a 
marked reduction in airflow (hypopnea) during sleep.
18
 Hypopneas result from a decrease 
of ≥30% in respiratory effort accompanied by ≥4% oxygen desaturation,19 although 
alternative definitions are often reported in the literature.
  
Apneas and hypopneas that last 
at least 10 seconds are considered clinically significant.  In some individuals, these 
reductions in airflow may persist for 30-60 seconds.
12
 Sleep apnea is further classified as 
central, obstructive, or mixed.  Central apneas result from a lack of neural output from the 
brainstem respiratory centers, which leads to a lack of inspiratory effort.
20
 In short, the 
brain temporarily stops sending signals to the muscles that control breathing.  Obstructive 
apneas result from a closure or collapse of the upper airway during sleep, preventing 
airflow into the lungs.  Mixed apneas are a combination of central and obstructive apneas.  
Mixed apneas typically start out as central; however, the apnea persists after respiratory 
effort commences due to collapse of the upper airway, resulting in obstruction to airflow.
12  
2.2 Obstructive Sleep Apnea  
 Among the classifications of sleep apnea, obstructive sleep apnea (OSA) is the 
most common.  Studies report 1 in 5 Americans have at least mild OSA while 1 in 15 have 
moderate to severe forms of the disease.
21
 Of these, more than 80% are unaware of their 
condition.
2,3  
OSA is a significant medical condition that can drastically decrease quality of 
life in severe cases when left untreated.  OSA is also the leading cause of excessive 
 4 
daytime sleepiness and is associated with the development of hypertension,
5
 cardiovascular 
disease,
6 
metabolic syndrome,
7 
stroke, and death.
8
 In addition, OSA is reported to increase 
depression by at least twofold in patients who suffer from the disease.
9  
2.3 Polysomnography  
 In order to determine if a person has sleep apnea, a diagnostic test must be 
performed.  Polysomnography (PSG) is considered the “gold standard” for diagnosing 
sleep apnea.  During the overnight stay in a sleep laboratory, respiratory parameters are 
measured to determine a person’s apnea-hypopnea index (AHI).19 The AHI, or number of 
obstructive events per hour of sleep, is the key measure for OSA severity: AHI >5 is 
interpreted as mild OSA; AHI >15 as moderate OSA; AHI >30 as severe OSA.  Although 
PSG is the formal method of clinically diagnosing sleep apnea, the number of sleep 
laboratories in the country is insufficient for the increasing population prevalence of the 
disease.
10
 Furthermore, the high cost and inconvenience of PSG sleep studies often 
discourage individuals from seeking this type of evaluation.  Recent clinical guidelines 
suggest unattended home testing, in conjunction with a comprehensive sleep evaluation, is 
an option for patients with a high pretest probability of moderate to severe apnea when 
initiation of treatment is urgent and PSG is not readily available.
22
 The National Institute  
for Health and Clinical Excellence (NICE) also states moderate to severe OSA can be 
diagnosed from patient history and a sleep study using oximetry or other monitoring 
devices unattended in the patient’s home.23 However, patients suspected of having OSA 
who receive a negative home test result should follow-up with PSG. 
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2.4 STOP: A Screening Questionnaire  
 Reliable screening tools, such as the 4-item STOP questionnaire, are useful in 
identifying a patient’s probability of having sleep apnea.  The STOP questionnaire was 
originally developed as a pre-surgical screening tool for OSA and represents a simple and 
efficient method of identifying patients at risk for the disorder.
24 
The questionnaire, using 
the acronym STOP, has patients report loud snoring, tiredness during the daytime, 
observed gaps in breathing, and a history of high blood pressure.  Patients with two or 
more affirmative responses are classified as high-risk for OSA, while patients with scores 
of <2 are classified as low-risk.  Sensitivity and specificity values for the STOP 
questionnaire are summarized in Supplementary Table 1.  The study by Chung et al. found 
sensitivity and specificity of the STOP questionnaire to be 66% and 60%, respectively, for 
detecting patients with mild OSA.
24 
The same study also suggests the STOP questionnaire 
may have a greater sensitivity for detecting patients with moderate and severe forms of 
OSA, with values of 74% and 80%, respectively.
24
 Specificity for detecting patients with 
moderate and severe forms of OSA was estimated to be 53% and 49%, respectively.  In 
comparison with other screening tools, the STOP questionnaire has been shown to have the 
highest methodological validity and reasonable accuracy when identifying patients at risk 
for OSA.
10
 
2.5 STOP-Bang 
 As a continuation of the STOP questionnaire, the STOP-Bang screening method 
includes additional measures of body mass index (BMI), age, neck circumference, and 
gender.  Clinical characteristics of BMI >35 kg/
 
m
2
, over 50 years of age, neck 
circumference >
 
40 cm, and male gender appear to increase the risk for OSA.  A STOP-
 6 
Bang score of ≥3 is classified high-risk for OSA, while scores of <3 are classified low-risk.  
Chung et al. estimate that the STOP-Bang has a higher sensitivity than the STOP for 
detecting moderate and severe cases of OSA:  93% and 100%, respectively.
24
 However, the 
specificity is lower: 43% and 37% for moderate and severe OSA, respectively, resulting in 
high false negative rate. Therefore, in this research study, we considered an individual at 
high-risk for OSA if STOP ≥2 in order to achieve a reasonably high level of sensitivity and 
acceptable level of specificity in detecting moderate or severe cases of OSA.    
2.6 Epworth Sleepiness Scale  
 Excessive daytime sleepiness is a cardinal feature of OSA.
 
 The Epworth 
Sleepiness Scale (ESS) is a screening tool used to measure an individual’s daytime 
sleepiness.  This 8-item questionnaire asks subjects to rate how likely they are to doze in a 
variety of daytime situations using the following criteria:  0=would never doze; 1=slight 
chance of dozing; 2=moderate chance of dozing; 3=high chance of dozing.  A score of ≥11 
indicates a high risk of excessive daytime sleepiness and a score of <11 is considered low 
risk. However, Gottlieb et al. found that a score >11 is present in only 35% of patients with 
severe OSA based on AHI.
25 
Although ESS is not a strong indicator of OSA on its own, it 
can be helpful in identifying persons at risk when used in conjunction with other methods.  
In this study, ESS was used to assess the relationship between OSA risk status and self-
reported degree of daytime sleepiness. 
2.7 Pulse Oximetry  
 In addition to screening questionnaires, overnight pulse oximetry provides a non-
invasive, economical method of determining risk for OSA.  The portable pulse oximeter 
continually monitors and records oxygen saturation (SpO2) of a peripheral artery during 
 7 
sleep and can detect a fall in SpO2 caused by respiratory events.
26 
Oxygen saturation levels 
and heart rate are recorded simultaneously and the pulse oximetry device can provide the 
following information: oxygen desaturation index of 2% (ODI2), 3% (ODI3), or 4% 
(ODI4) and cumulative time spent below 90% oxygen saturation (CT90).  ODI refers to the 
number of events per hour of 2%, 3%, or 4% or greater decrease in oxygen saturation from 
the baseline level, typically determined during the first few minutes of recording while the 
patient is awake.  Cooper et al. determined that the sensitivity and specificity of pulse 
oximetry as a single predictor for identifying OSA was dependent on the AHI, concluding 
that pulse oximetry is more effective for screening patients with moderate to severe sleep 
apnea than for milder severity.
27 
The study found sensitivity was 100% and specificity 95% 
for patients with an AHI of ≥25 events per hour, but both sensitivity and specificity 
decreased as AHI decreased.  Other studies reveal a broad range of sensitivity and 
specificity values.
28
 Overall, the body of evidence concludes that the combination of a 
screening questionnaire with pulse oximetry improves the specificity of oximetry as a 
screening tool for sleep apnea.
29 
Oeverland et al. found ODI3 to be the optimal 
measurement for determining OSA risk, which resulted in 91% sensitivity and 67% 
specificity in individuals with at least mild OSA, and 86% and 88% in moderate to severe 
cases (Supplementary Table 2).
30 
Furthermore, Niijima et al. concluded that a threshold of 
ODI3 ≥10 reduced the number of undetected OSA due to false negatives.26 Similarly, 
Nigro et al. noted sensitivity and specificity to be 88% and 94%, respectively, in moderate 
OSA cases at a threshold of ODI3 >10.5.
31 
The diagnostic usefulness of CT90 ≥1% has also 
been evaluated.  Gyulay et al. found that CT90 ≥1% identified patients with at least 
moderate OSA with sensitivity of 93% and specificity 51%.
32
 Furthermore, Gyulay et al. 
 8 
suggest that oximetry data should be analyzed by calculating both CT90 and ODI in order 
to obtain the highest sensitivity and specificity for detecting OSA.
32 
Therefore, in this 
research study an individual was considered high-risk for OSA if ODI3 ≥10 events per 
hour or CT90 ≥1% of the recording period.
 
2.8 Significance to Dental Professionals  
 OSA is one of the most common undiagnosed chronic diseases.  Dental 
professionals represent an important resource for identifying individuals at risk for OSA 
due to the frequency of examinations.  Furthermore, many adults do not visit their primary 
care physician on a frequent basis.  Recent research suggests approximately 23% of the 
adult population who did not have contact with a physician did see their dentist on a 
regular basis.
17 
This relationship gives the dental practitioner the opportunity to closely 
monitor the patient’s medical health.2 For example, dental professionals play an important 
role in detecting undiagnosed and uncontrolled hypertension among patients by monitoring 
blood pressure at dental appointments.  However, research shows that less than 50% of 
dentists are familiar with the common signs and symptoms of sleep apnea.
16 
For this 
reason, it is important to educate dentists and dental hygienists in the recognition and 
screening of sleep apnea.  Accepting dentistry’s position as a part of a team dedicated to 
the study of sleep related disorders is useful to proper and ethical participation in the 
screening and treatment of sleep apnea.
33  
At present, there are no accepted guidelines for 
screening patients in the dental office.  Neither is it known whether patients who screen 
high-risk for OSA subsequently seek consultation with their physicians regarding the 
results of the screening tests. 
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2.9 Study Purpose 
 OSA is increasing in prevalence, widely undiagnosed, and a precursor of 
significant pathology.
1-9
 Collectively, these features point to the salience of OSA 
screening.  Therefore, the purpose of this study was to investigate the feasibility of 
screening for OSA risk in a dental practice setting and to examine the response of patients 
to a recommendation for physician evaluation.  
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3.  INTRODUCTION AND REVIEW OF THE LITERATURE 
 Obstructive sleep apnea (OSA) is increasing in prevalence, widely undiagnosed, 
and a precursor of significant pathology.  Marked by a lapse in breathing or a significant 
reduction of airflow during sleep, moderate OSA is estimated to affect 10% of men and 
3% of women aged 30-49 years and 17% and 9% of men and women, respectively, aged 
50-70 years.
1 
Additionally, more than 80% of moderate to severe OSA cases remain 
undiagnosed.
2,3
 The percentage of OSA among American adults is steadily increasing with 
the rising rate of obesity.  Young et al. found that obesity is the strongest contributing 
factor to OSA, which strengthens the assumption that the increasing prevalence of OSA 
parallels that of obesity.
4
 OSA is the leading cause of excessive daytime sleepiness and is 
associated with the development of hypertension,
5
 cardiovascular disease,
6
 metabolic 
syndrome,
7
 stroke,
8
 and depression.
9
 When left untreated, OSA is a significant medical 
condition that can impair quality of life.   
At present, polysomnography (PSG) provides formal diagnosis of sleep apnea; 
however, insufficient numbers of sleep laboratories and the prohibitive cost of their 
services may discourage this type of evaluation.
10
 As disease awareness increases, so does 
the demand for convenient and economical methods of diagnosing patients with OSA and 
of screening individuals to identify those at risk for OSA.       
 To assess a possible need for PSG, questionnaires such as the STOP, STOP-Bang, 
and Epworth Sleepiness Scale (ESS) are becoming widely accepted for their use in 
screening for OSA risk in clinical settings.  Specifically, the STOP and STOP-Bang 
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questionnaires have been shown to have the highest methodological validity, reasonable 
accuracy, and simplicity.
10
 Likewise, home sleep testing devices measuring pulse oximetry 
provide objective data and often comparable diagnostic outcomes as those yielded with 
conventional PSG particularly for patients with more severe disease.
11-13
   
 As with many systemic diseases, OSA may have an association with periodontitis.  
Ahmad et al. found that dental patients who screened high-risk for OSA were four times 
more likely to have moderate or severe periodontitis than those who screened low-risk 
(95% CI: 1.5, 11.4).
14
 Similarly, a study conducted by Gunaratnam et al. suggests that the 
prevalence of periodontitis is greater in patients with OSA.
15
 The high prevalence of 
undiagnosed sleep apnea and its potential relationship with chronic periodontitis suggest 
that dentists and dental hygienists could provide a valuable service to patients by 
incorporating sleep apnea screening into their practice.
16
 This is especially important for 
dental patients who do not regularly access general health care.  An estimated 23% of 
adults who visit their dentist regularly do not have contact with a physician.
17
 By 
incorporating OSA screening into clinical practice, dentists and dental hygienists can alert 
patients about the need for follow-up with a physician, when warranted.  Therefore, the 
aim of this study was to investigate the feasibility of screening for OSA risk in a dental 
practice and to examine the response of patients to a recommendation for physician 
evaluation. 
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4.  MATERIALS AND METHODS 
4.1 Study Population 
 The setting for this cross-sectional study was a community-based dental practice 
located in Raleigh, NC, USA.  The study population was sampled using a non-probability 
convenience sampling method where subjects were selected on the basis of their 
accessibility and proximity to the investigator. 
All patients scheduled for preventive dental care from April through September 
2013 received an informational email prior to their scheduled visit that described the study.  
Upon presenting for their visit, potential subjects were presented with written details of the 
study and description of the incentive for participation.   Participation incentive was a $10 
gift card.  Interested volunteers aged 18 years or older who were not pregnant and had not 
previously been diagnosed with OSA were eligible for enrollment.  The study was 
approved by the Institutional Review Board at the University of North Carolina at Chapel 
Hill and all subjects gave written informed consent. 
4.2 Data Collection 
 Enrolled subjects were issued a self-administered pencil and paper screening 
questionnaire to complete at home (Appendix A) that collected information about age, 
gender, weight, height, daytime sleepiness (Epworth Sleepiness Scale), and the STOP 
questions (snoring, tiredness during the day, observed apnea, and self-reported presence of 
high blood pressure).  The investigator or research assistant measured each subject’s neck 
 13 
circumference with a tape measure at the location just below the laryngeal prominence and 
recorded this measurement on the screening questionnaire.  
In addition, a portable pulse oximetry device (VirtuOx VPOD-Ultra) for overnight 
monitoring of SpO2 was issued to each subject. This was accompanied by detailed written 
recommendations (Appendix B) and verbal instructions to wear the device overnight on a 
single night while asleep for a minimum of four hours. Subjects were asked to return the 
completed questionnaire and device to the dental practice in a sealed envelope.  A 
numerical reference number recorded at the top of the screening questionnaire identified 
subjects.  No personal identifying data were included on the study materials.  
Questionnaire data were transcribed by hand to a Microsoft Excel spreadsheet, and stored 
data from the pulse oximeter were uploaded into the device’s web-based computer 
program by the investigator.   
4.3 Risk Assessment 
 (1) The validated 4-item STOP screening questions classified subjects high-risk for 
OSA in the presence of ≥2 of: loud snoring; daytime tiredness; witnessed apnea; 
hypertension.
24
  
(2) Consistent with guidelines in the literature, overnight pulse oximetry classified 
high-risk for OSA as the presence of either: oxyhemoglobin saturation below 90% (CT90) 
for ≥1% cumulative recording time; or oxygen desaturation index (ODI3) ≥10 events/hour 
in which oxyhemoglobin saturation decreased ≥3% from baseline.26,30,32 
4.4 Follow-up Procedures 
 Subjects were notified by mailed letter (Appendix C) of their OSA risk status 
according to each screening instrument.  Those classified as high-risk on one or both 
 14 
instruments were advised to seek physician evaluation within three months.  All subjects 
were contacted via telephone two weeks after mailing the letter to discuss screening results 
and inquire about the likelihood of physician consultation.  Subjects were phoned again 
three months later to determine whether or not they had sought evaluation. 
4.5 Statistical Analysis 
 Data from the spreadsheet were imported into Stata 13.1 (StataCorp. 2013. Stata 
Statistical Software: Release 13. College Station, TX: StataCorp LP) for statistical 
analysis.  To address the study aim, analysis compared the physician-consulting behavior 
of subjects according to OSA risk status. The binary dependent variable classified these 
subjects as either having had a physician consultation about the OSA screening results 
within three months, or not having had a consultation.  In univariate analysis examining 
the relationship of subjects’ characteristics and OSA risk status, Pearson’s chi-square test 
was used for categorical variables. The two-sample Wilcoxon rank-sum (Mann-Whitney) 
test for non-parametric continuous variables was used to compare components of the 
STOP questionnaire with the components of pulse oximetry: CT90 and ODI3.  In 
multivariate analyses, prevalence ratios (PR) with 95% confidence limits (95% CL) were 
estimated using a log-binomial regression model in which the independent variable was 
OSA risk classified as high-risk on: neither instrument; STOP only; pulse oximetry only; 
or both instruments.  Computationally, the prevalence ratio is the ratio of prevalence 
among the exposed to the prevalence among the unexposed.  In the context of this study, 
prevalence refers to the percentage of subjects who sought physician evaluation, while 
exposure refers to their OSA risk status.  Prevalence ratios were computed instead of the 
more commonly used odds ratios because when prevalence is not a rare event (<10%), the 
 15 
odds ratio overestimates the strength of association.  To adjust for potential confounding of 
the relationship between OSA risk status and physician evaluation, multivariable models 
included covariates of age, sex, body mass index, and daytime sleepiness.     
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5. RESULTS 
5.1. Feasibility of Screening 
A total of 124 subjects enrolled in the study. All subjects responded to all four 
STOP questions.  A pulse oximetry recording of four or more hours was obtained from 119 
(96%) of the subjects. No recording was obtained from one subject and for four subjects, a 
recording was obtained but it was less than four hours.  Because these five subjects did not 
comply with the instructions for the screening protocol, their data were omitted from 
analysis. The mean duration of the recordings from the 119 subjects who completed the 
screening protocol as instructed was 7.0 hours (sd: 1.5 hours). 
5.2 Demographics of Subjects who Screened High-Risk 
Of the 119 subjects, the mean age was 51 years, 47.9% was male, and 24.4% was 
obese. Fifty percent (50.4%) screened high-risk based on the STOP questionnaire, 58% 
screened high-risk based on pulse oximetry, and 31.9% screened high-risk on both 
instruments. Seventy-seven percent (76.5%) of subjects screened high-risk on at least one 
instrument.  
Men were significantly more likely than women to screen high-risk on the STOP 
questions (Table 1). An inverted U-shaped relationship observed between age and OSA 
risk using the STOP questions differed notably from the monotonic increase in OSA risk 
across age groups observed for pulse oximetry (Table 1, Figure 1A). However, the 
instruments were more concordant in the positive and generally linear relationship between 
BMI and OSA risk (Table 1, Figure 1B).  When the two sleep parameters assessed by 
 17 
pulse oximetry (CT90 and ODI3) were assessed individually across BMI categories, both 
parameters were closely aligned (± 0.2) with probabilities determined by the STOP  
(Figure 1C).  
Subjects whose neck circumference exceeded established thresholds for risk of 
OSA were significantly more likely to screen high-risk based on the STOP questions but 
not based on pulse oximetry (Table 1).  Overall, 17.7% of adults reported excessive 
daytime sleepiness, a cardinal symptom of OSA. Yet no significant relationship was 
observed between daytime sleepiness and risk for OSA on either instrument (Table 1). 
5.3 Concordance Among Screening Measures 
The STOP questionnaire identified the highest percentage of patients at high-risk 
(50%) followed by the CT90 parameter (47%) and then the ODI3 parameter (43%; Figure 
2).  There was greater dissimilarity than similarity in the screening results from the 
instruments.  Specifically, of those subjects who screened high-risk on at least one 
instrument (n=91; 76.5% of total), only 42% screened high-risk on both the STOP and 
pulse oximetry; whereas, 24% screened high-risk on the STOP alone and 34% on oximetry 
alone.  Of subjects who screened high-risk on pulse oximetry (n= 69), there was 
dissimilarity in the results from the two oximetry parameters.  Only 55% screened high-
risk on both CT90 and ODI3; whereas, 26% screened high-risk on the CT90 parameter 
alone, and 19% of subjects screened high-risk on the ODI3 parameter alone.  Of the total 
number of subjects (n=119), only 21% (n=25) screened high-risk on the STOP 
questionnaire and both sleep parameters assessed by pulse oximetry. 
Thirty-seven percent (n=22) of subjects who screened low-risk on the STOP 
questionnaire screened high-risk on the CT90 parameter of pulse oximetry (Figure 2).  
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Likewise, 37% (n=22) of subjects who were low-risk on the STOP were high-risk on the 
ODI3 measure.  Being overweight or obese increased the likelihood of screening high-risk 
on the oximetry parameters for subjects who screened low-risk on the STOP (Figure 1D). 
To illustrate, for normal weight adults who screened low-risk based on the STOP 
questionnaire, the probability of screening high-risk based on CT90 and ODI3 
approximated 0.30.  The probabilities were higher and similar for obese I adults, 
approximating 0.8.  That is, an obese adult who screened low-risk on the STOP 
questionnaire still had an 80% chance of screening high-risk on either pulse oximetry 
parameter.  Subjects in the obese II/III category (n=8) had a 50% chance of screening high-
risk on the CT90 given low-risk based on STOP questions; however, no subjects in this 
category were identified at risk based on the ODI3 parameter alone.  
Whether subjects who screened high-risk on the CT90 also screened high-risk on 
the ODI3 sleep parameter was also determined, in part, by BMI.  For obese adults who 
screened high-risk based on the CT90 parameter, the probability of also screening high-risk 
based on ODI3 approximated 0.8 (Figure 1D).  However, the probability was lower for 
normal weight adults, approximating 0.4.  That is, normal weight adults who screened 
high-risk on the CT90 parameter had only half the likelihood of also screening high-risk on 
the ODI3 parameter compared to subjects who were obese. 
5.4 Pulse Oximetry Results   
Consistent with the high percentage of subjects who screened high-risk on pulse 
oximetry (58%), the mean values of CT90 and ODI3 were substantially above zero and the 
standard deviations were high: 5.9% (sd: 12.8%) and 11.3 events/hour (sd: 10.5), 
respectively (Table 2). The corresponding median values were 1% and 8 events/hour, 
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respectively.  A greater cumulative time with oxyhemoglobin saturation below 90% (CT90) 
tended to be associated with high-risk for OSA based on the STOP questionnaire (P=0.022, 
Table 2).  
5.5 Calculation of Risk Status Based on the STOP-Bang 
Although the STOP-Bang questionnaire was not used to advise subjects on their 
risk for OSA, it was determined that 80 subjects (67%) were at high-risk based on this 
instrument.  As such, the STOP-Bang identified 17% of the subjects at high-risk who were 
not identified by the STOP alone. 
5.6 Physician-Consulting Behavior 
Physician consultation information was obtained from 111 of the 119 subjects 
(93.3%).  Of those who screened high-risk for OSA by any instrument and were advised to 
consult with their physician about their risk of sleep apnea, 47.1% (n=40) sought physician 
evaluation within three months of screening.  Of the 20 subjects at risk based on STOP 
questions alone, seven (35.0%) sought physician consultation.  On the other hand, of the 
30 subjects screening at risk based on pulse oximetry alone, 43.3% (n=13) consulted their 
physician.  
A more valid comparison is that of subjects classified high-risk on the STOP 
questions alone compared to subjects who were classified high-risk on pulse oximetry 
alone. In this comparison there was no difference in consultation behavior (PR=1.42, 95% 
CL: 0.51, 3.94).  Likewise subjects classified high-risk based on both instruments were not 
significantly more likely to consult a physician than those at risk on the STOP questions 
alone (PR=1.91, 95% CL: 0.73, 4.99).  
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6. DISCUSSION 
   This study sought to investigate the feasibility of OSA screening in a dental 
practice setting, and to examine patient response to a recommendation for physician 
evaluation.  Overall, 47.1 % (n=40) of individuals who screened high-risk for OSA on 
either instrument sought physician evaluation.  Hence, screening motivated almost half of 
those at elevated risk for OSA to consult a physician.  Although it was expected that 
subjects who screened high-risk on both questionnaire and pulse oximetry would be more 
likely to seek evaluation than those who screened high-risk on one measure alone, this 
finding was not supported by the current study.  Rather, subjects were just as likely to seek 
evaluation when screened high-risk on one instrument versus both.  However, it remains 
unknown if similar results would have been obtained if only one instrument had been used 
with separate groups of subjects.     
6.1 Physician Follow-Up in Other Studies 
 
 Creanor et al. report that over 87% of individuals recognize the importance of 
screening for medical conditions among dental practitioners, supporting the proposed 
concept of a high acceptance of OSA screening among dental patients.
34 
However, support, 
in principle, does not necessarily mean that patients will take the next step in consulting 
with their physicians.  Hypertension is perhaps the most common medical condition 
screened in the dental office that patients recognize as important.  A previous study of the 
efficacy of hypertension screening in the dental office reported 97.1% physician follow-up 
by patients within a 3-year period.
35 
Unlike this previous study, the current study did not 
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account for those patients who followed-up after the 3-month period, which may result in a 
response rate comparable to hypertension screening over a 3-year period.   
An objective of Healthy People 2020 is to “increase the proportion of persons with 
symptoms of obstructive sleep apnea who seek medical evaluation” to 28%.36 Based on 
the 2005-2006 and 2007-2008 National Health and Nutrition Examination Survey cycles, 
25.5% of patients with symptoms seek medical evaluation.  Thus, it is encouraging that a 
substantially higher percentage of individuals, about 35%, sought medical evaluation when 
made aware of symptoms of OSA through screening administered by the dental office. 
6.2 Factors Associated with High-Risk 
 
 The current study found that men were significantly more likely to screen high-risk 
on the STOP questionnaire than women (61% compared to 40).  Similarly, a gender 
difference was suggested by the oximetry screening results, although it did not attain 
statistical significance.  These findings are consistent with community-based studies that 
report a 2-3:1 ratio in the prevalence of OSA for men compared to women.
37,38
 A number 
of factors might explain, at least in part, the gender difference.  For example, men have a 
greater tendency for android fat distribution, resulting in a larger neck circumference.
39 
Neck circumference >40 cm appears to increase an individual’s risk for OSA.24 However, 
increased neck circumference only partially accounts for the high prevalence of OSA in 
men compared to women.  It has also been suggested that functional differences in the 
upper airway may contribute to a higher prevalence of OSA in males.
38 
Similarly, another 
study suggests that women may have a protective advantage over men that prevents airway 
collapse in some stages of sleep.
40
 Although more research is necessary to determine the 
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reasons for the gender difference, men tend to have higher prevalence of OSA than 
women.  
  The relationship of OSA risk and age differed between the STOP questionnaire and 
pulse oximetry. The probability of screening high-risk based on STOP questions alone 
increased with age until approximately 55 years of age and then decreased.  Individuals 
aged 45-54 had approximately 65% chance of screening high-risk for OSA compared to 
50% in subjects 55-64 years old and 45% of subjects 65 and older (Fig. 1A).  This result 
follows a similar trend reported by Young et al. which suggests prevalence of OSA may 
not continually increase with age.
37
 The finding suggests that age may not be a strong risk 
factor for OSA after the middle age or that the survival of individuals is poorer in older 
individuals who are not treated.  While probability of risk based on STOP questions did 
not consistently increase with age, OSA risk based on pulse oximetry followed a 
monotonic increase across all age groups, suggesting that factors other than the presence of 
OSA may have contributed to these positive screening results in the oldest individuals 
studied.    
  Oeverland et al. report optimal agreement between PSG and pulse oximetry based 
on the ODI3 in identifying individuals with OSA.
30
 Although both sleep parameters from 
the oximetry in the present study identified subjects at risk who were not identified by the 
STOP questionnaire, positive results on CT90 and ODI3 were not in strong concordance:  
Only about half of the patients who screened high-risk on one measure also screened high-
risk on the other.  In addition, CT90 identified a greater percentage (7% more) of the 
individuals at risk than ODI3.  The probability that the ODI3 parameter would indicate 
high-risk in subjects who were identified high-risk based on CT90 increased with BMI.  
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The dependency of high-risk status based on the oximetry parameters on BMI suggests 
their potential relationship with obesity hypoventilation syndrome (OHS).  OHS, a form of 
sleep disordered breathing, is defined by excessively slow or shallow breathing resulting 
from nighttime hypoxia.
41 
Therefore, high-risk status based on CT90 could reflect OHS in 
overweight subjects.  This could also account for the high percentage of subjects (58%) 
that screened high-risk on one or both pulse oximetry parameters in the present study. 
6.3 Implication to Screening Recommendations 
 The concurrent administration of two screening instruments yielded a large pool of 
subjects at risk for OSA.  Specifically, 77% screened high-risk for OSA on at least one 
instrument.  This percentage exceeds national prevalence estimates almost fourfold for 
mild or more severe OSA in the adult population.
1, 37 
Clearly this protocol is unsuitable for 
screening in a dental practice as its limited capacity to identify those without disease places 
additional burden on the healthcare system, while misdirecting scarce healthcare resources 
away from people with genuine medical need.  Concurrent administration of three 
screening measures increases sensitivity at the expense of specificity.  These values can be 
predicted from the sensitivities and specificities of the individual measures and 
approximate 0.10 and 0.33, respectively, for detecting moderate to severe OSA using the 
protocol of this study.
42
 
Based on findings of this study, a protocol is recommended that would screen 
subjects using the STOP questionnaire and limit administration of pulse oximetry only to 
those who screen positive.  The use of a sequential protocol has the benefit of a higher 
specificity at the expense of a lower sensitivity.
42 
In the present study, only 32% of the 
subjects met criteria for high-risk based on this sequential protocol in contrast to the 77% 
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found at high-risk using dual administration (Figure 2).  This percentage is notably lower 
than that from use of any of the three screening measures individually.  The predicted 
sensitivity and specificity of the sequential protocol both approximate 0.74 for detecting 
moderate to severe OSA.   
An alternative sequential protocol is to screen subjects first with the STOP-Bang 
questionnaire, then administer pulse oximetry to only those individuals who screened 
positive.  Based on the available estimates published in the literature, the predicted 
sensitivity is 0.92 and specificity is 0.69 for detecting moderate to severe OSA using this 
protocol.  Although the STOP-Bang identifies a high proportion of false high-risk cases, 
the subsequent administration of pulse oximetry to those who screen high-risk would 
eliminate many of these from unnecessary physician referral.   
6.4 Representativeness of the Study Sample  
 The study population was comprised of 124 dental patients selected by non-
probability sampling from a community-based dental practice.  Of these, 119 provided 
adequate data for analysis.  Self-selection bias is highly likely.  For example, only subjects 
who perceived themselves at risk were motivated to participate in the study.  Alternatively, 
only those patients who had received care from the investigator dental hygienist were 
prompted to volunteer for screening.  However, such bias is not unique to this study. 
6.5 OSA Screening in the Dental Practice 
  
 The simplicity of the screening instruments described in this study makes it feasible 
for dental practitioners to incorporate a protocol into clinical practice.  Research shows that 
patient response rate decreases as the length of the questionnaire increases.
43 
The STOP 
and STOP-Bang questionnaires can be answered in less than one minute, making them a 
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valuable screening tool in busy clinical settings.
24
 Further, the mnemonics STOP and 
STOP-Bang may serve as a useful reminder to clinicians when utilizing the 
questionnaires.
24 
The pulse oximetry device used in the current study was also well 
accepted among patients for its ease of use.  Simple written instructions guided patients on 
the correct placement of the finger probe and powering the device on and off.  Moreover, 
patients reported the device was comfortable to wear, and 96% (n=119) were able to wear 
the oximeter for the recommended minimum of four hours during sleep.  Portable pulse 
oximetry devices offer some advantage to more elaborate home sleep testing devices when 
determining individuals at risk for OSA.  For instance, portable pulse oximeters typically 
require fewer electrode or signal leads and are less costly than traditional type III home 
sleep testing devices.
11 
 The potential value of OSA screening in dental practices has been noted in only a 
few studies.  In Levendowski et al., 67% of men and 28% of women were predicted to be 
at risk for at least mild OSA by the Apnea Risk Evaluation System (ARES™).16 The 
results were similar to the current study, which predicted 61% and 40% of men and 
women, respectively, to be at high risk for OSA by the STOP questionnaire.  Moreover, 
the previous study found a high concordance between predicted risk of OSA by 
questionnaire and the degree of OSA determined by overnight sleep study.
16 
This finding 
suggests that dental practitioners can provide a valuable service to patients by 
incorporating OSA screening into practice.     
 Screening for undiagnosed medical conditions in the dental office has been 
proposed as a potentially valuable public health service.  A recent study found that medical 
screenings in the dental office can save the health care system between $42.4 and $102.6 
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million over a one-year period.
44 
The same study suggests that oral health professionals can 
play a role in detecting chronic disease such as diabetes and hypertension, which have also 
been linked to OSA.  For this reason, OSA screening in the dental office can not only lead 
to early detection of the disease, but may also result in substantial health care savings. 
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7. Conclusion 
 
 
 The findings of this study have implications for the establishment of a protocol for 
OSA screening in the dental office.  The simplicity of the screening instruments makes it 
feasible for dental practitioners to incorporate into clinical practice.  Although the 
screening measures used in this study identified an unreasonably high proportion of 
patients at risk for OSA based on current epidemiological studies, nearly half of high-risk 
subjects did follow a recommendation to seek physician consultation based on the outcome 
of their screening.  Future studies should include sequential testing in order to eliminate 
unnecessary physician referral.  While dental practitioners can help identify patients with 
risk factors, OSA is a potentially life-threatening disease; therefore, dentists and physicians 
must work as a team in the identification and referral of individuals at risk for OSA and the 
subsequent diagnosis and treatment of clinically significant disease.   
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Figures 1A to 1D depict predicted probabilities of screening high risk for OSA. Probabilities are from a 
logistic regression model that adjusts for sex and BMI (1A) or sex and age (1B, 1C, 1D). 1A plots probability 
based on STOP questions and pulse oximeter across age groups. 1B plots probability based on the STOP and 
pulse oximeter across BMI categories. 1C plots probability based on STOP and the two parameters of pulse 
oximetry (ODI, CT90). 1D plots conditional probability of CT90 given low risk on STOP, ODI given low risk 
on STOP, and ODI given high risk on CT90. 
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Figure 2: Venn diagram of numbers of subjects who responded at high risk on none or each of the three 
screening measures, alone or in combination.  
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 Table 1: Percentage of study subjects 
(a)
 who screened high-risk for OSA based on the STOP questionnaire 
(b)
, pulse oximetry 
(b)
, both instruments and neither 
instrument.  
 
N (%) 
 
STOP  
questionnaire 
(c)
 
P-value 
 
Pulse 
oximetry 
(d)
 
P-value 
 
Both 
instruments 
P-value 
 
Neither 
instrument 
P-value 
Total 119 (100.0)  50.4   58.0   31.9   23.5  
              
Sex 
  
           
  Female 62 (52.1)  40.3 0.022  53.2 0.273  25.8 0.135  32.3 0.019 
  Male 57 (47.9) 
 
61.4   63.2   38.6   14.0  
              
Age (years)  
 
           
<35 20 (16.8)  25.0 0.041  10.0 <0.001  5.0 0.005  70.0 <0.001 
35–44 23 (19.3)  56.5   34.8   17.4   26.1  
45–54 24 (20.2)  66.7   50.0   37.5   20.8  
55–64 27 (22.7)  59.3   85.2   51.9   7.4  
≥65 25 (21.0)  40.0   96.0   40.0   4.0  
 
 
 
           
Body mass index (kg/m
2
) 
(e)
  
 
           
Normal (18.5-24.9) 47 (39.5)  34.0 0.010  51.1 0.059  19.2 0.012  34.0 0.023 
Overweight (25.0-29.9) 43 (36.1)  53.5   51.2   30.2   25.6  
Obese Class I (30.0-34.9) 21 (17.7)  76.2   76.2   57.1   4.8  
Obese Class II/III (≥35.0) 8 (6.7)  62.5   87.5   50.0   0.0  
 
 
 
           
Neck circumference (cm) 
(f)
  
 
           
Low risk (<40) 60 (50.4)  33.3 <0.001  50.0 0.075  18.3 0.001  35.0 0.003 
High risk (≥40) 59 (49.6)  67.8   66.1   45.8   11.9  
 
 
 
           
Excessive daytime sleepiness 
(g)
  
 
           
No excess sleepiness (≤10) 98 (82.4)  49.0 0.497  60.2 0.289  31.6 0.879  22.5 0.548 
Excessive sleepiness (>10) 21 (17.7)  57.1   47.6   33.3   28.6  
(a)  Values are row percentages. The percentage of subjects who screened at low risk for OSA according to each screening device is not reported. 
(b) These are not mutually exclusive categories 
(c) Classifies high risk for obstructive sleep apnea (OSA) as the presence of ≥2 of: loud snoring; daytime tiredness; witnessed apnea; hypertension 
(d)  Classifies high risk for OSA as cumulative percentage of recording time with oxyhemoglobin saturation below 90% (CT90) and/or the oxygen desaturation index (ODI) defined as ≥10 events per hour 
in which the oxyhemoglobin saturation is decreased by ≥3% from baseline  
(e)  World Health Organization categories 
(f)  Neck circumference threshold from: Chung et al. STOP questionnaire: a tool to screen patients for obstructive sleep apnea. Anesthesiology 2008;108(5):812-21.  
(g)  Epworth Sleepiness Scale
3
0
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Table 2: Summary statistics for the relationship of CT90 
(a)
 and ODI3 
(b)
 with STOP questionnaire risk categories 
 
Cumulative time with oxyhemoglobin 
saturation below 90% (CT90)
 
 
Oxygen desaturation index of 3% (ODI3) 
 
Mean (sd) 
Median 
(IQR) 
P-value 
(c)
 
 
Mean (sd) Median (IQR) P-value 
(c)
 
Total 5.9 (12.8) 1 (0, 5)   11.3 (10.5) 8 (3, 17)  
        
STOP questionnaire        
Low risk for OSA 4.8 (11.7) 1 (0, 3) 0.022  9.7 (9.0) 8 (2, 14) 0.119 
High risk for OSA 6.9 (13.8) 2 (0, 7)   12.8 (11.7) 9 (4, 20)  
(a) Cumulative percentage of recording time with oxyhemoglobin saturation below 90% 
(b) Number of events per hour in which the oxyhemoglobin saturation is decreased by ≥3% from baseline 
(c) Two-sample Wilcoxon rank-sum (Mann-Whitney) test, nonparametric 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
32 
 
Table 3: Prevalence ratios (PR) and 95% confidence limits (CL) for consulting a physician about obstructive sleep 
apnea following OSA risk screening initiated in a dental clinic (n=111) 
 PR 95% CL for PR P-value 
 
   Low risk for OSA on both instruments 0.19 0.04, 0.95 0.043 
High risk on STOP, low risk on pulse oximetry [referent]    
High risk on pulse oximetry, low risk on STOP 1.42 0.51, 3.94 0.502 
High risk for OSA on both screening instruments 1.91 0.73, 4.99 0.188 
Age per decade 0.91 0.70, 1.19 0.487 
Female sex [referent]    
Male sex  0.72 0.39, 1.33 0.287 
Body mass index 0.99 0.94, 1.05 0.856 
Intercept 0.71 0.09, 5.42 0.744 
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Supplementary Table 1: Sensitivity and specificity of STOP and STOP-Bang
22 
   
   Sensitivity (%)  Specificity (%) 
AHI >5 
  STOP   65.6    60.0 
  STOP-Bang  83.6    56.4 
AHI >15 
  STOP   74.3    53.3 
  STOP-Bang  92.9    43.0  
AHI >30 
  STOP   79.5    48.6 
  STOP-Bang  100.0    37.0   
AHI= apnea-hypopnea index 
STOP= snoring, tiredness, observed apnea, and high blood pressure 
STOP-Bang= STOP questionnaire including BMI, age, neck circumference, and gender 
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Supplementary Table 2: Sensitivity and specificity of the Oxygen Desaturation Index (ODI)
28 
   
   Sensitivity (%)  Specificity (%) 
AHI >5 
  ODI3   0.91    0.67 
  ODI4   0.73    1.00 
AHI >15 
  ODI3   0.86    0.88 
  ODI4   0.64    1.00 
AHI= apnea-hypopnea index 
ODI3= oxygen desaturation index of 3% 
ODI4= oxygen desaturation index of 4% 
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APPENDIX A- SCREENING QUESTIONNAIRE
 
 
 
	 SLEEP	APNEA	SCREENING	QUESTIONNAIRE	 Participant	#______	
	
	 	
	 DATE:	__________	 GENDER	(M/F):	__________	 AGE:	__________	 WEIGHT:	_________	lbs	
	 	 HEIGHT:	______	feet	______	inches	 NECK	CIRCUMFERENCE:	_________	inches	 	
Answer	No	or	Yes	to	the	following	four	questions	by	checking	the	box	that	applies.			
Do	you	snore	loudly	(louder	than	talking	or	loud	enough	to	be	heard	through	
closed	doors)?	
No	 Yes	
0	 1	
	 	 	
Do	you	often	feel	tired,	fatigued,	or	sleepy	during	the	daytime?	
No	 Yes	
0	 1	
	 	 	
Has	anyone	observed	you	stop	breathing	during	your	sleep?	
No	 Yes	
0	 1	
	 	 	
Do	you	have,	or	are	you	being	treated	for,	high	blood	pressure?	
No	 Yes	
0	 1	
	
Check	the	box	that	describes	how	likely	are	you	to	doze	off	or	fall	asleep	in	the	following	situations,	in	contrast	
to	feeling	just	tired.		This	refers	to	your	usual	way	of	life	in	recent	times.		Even	if	you	have	not	done	some	of	these	
things	recently,	try	to	work	out	how	they	would	have	affected	you.		
Sitting	and	reading	
Never		
doze	
Slight	chance		
of	dozing	
Moderate	chance	
of	dozing	
High	chance		
of	dozing	
0	 1	 2	 3	
	 	 	 	 	
Watching	television	
Never		
doze	
Slight	chance		
of	dozing	
Moderate	chance	
of	dozing	
High	chance		
of	dozing	
0	 1	 2	 3	
	 	 	 	 	
Sitting	inactive	in	a	public	place	(e.g.	a	theater	or	
a	meeting)	
Never		
doze	
Slight	chance		
of	dozing	
Moderate	chance	
of	dozing	
High	chance		
of	dozing	
0	 1	 2	 3	
	 	 	 	 	
As	a	passenger	in	a	car	for	an	hour	without	a	
break	
Never		
doze	
Slight	chance		
of	dozing	
Moderate	chance	
of	dozing	
High	chance		
of	dozing	
0	 1	 2	 3	
	 	 	 	 	
Lying	down	to	rest	in	the	afternoon	
Never		
doze	
Slight	chance		
of	dozing	
Moderate	chance	
of	dozing	
High	chance		
of	dozing	
0	 1	 2	 3	
	 	 	 	 	
Sitting	and	talking	to	someone	
Never		
doze	
Slight	chance		
of	dozing	
Moderate	chance	
of	dozing	
High	chance		
of	dozing	
0	 1	 2	 3	
	 	 	 	 	
Sitting	quietly	after	lunch	when	you’ve	had	no	
alcohol	
Never		
doze	
Slight	chance		
of	dozing	
Moderate	chance	
of	dozing	
High	chance		
of	dozing	
0	 1	 2	 3	
	 	 	 	 	
In	a	car,	while	stopped	for	a	few	minutes	in	
traffic	
Never		
doze	
Slight	chance		
of	dozing	
Moderate	chance	
of	dozing	
High	chance		
of	dozing	
0	 1	 2	 3	
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APPENDIX B- INSTRUCTIONS FOR OVERNIGHT PULSE OXIMETRY 
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APPENDIX C- FOLLOW-UP LETTER TO PARTICIPANTS 
 
 
 
 
 
 
 
 
 
 
(Date) 
 
 
Dear (participant), 
 
This letter is to inform you of the results from your recent sleep apnea screening.  
Our screening methods are not meant to diagnose, but rather to inform you of 
your risk for having sleep apnea.  Your results indicated the following:  
 
(High or Low) risk based on the validated screening questionnaire  
(High or Low) risk based on overnight pulse oximetry 
 
The only way to clinically diagnose and treat sleep apnea is through a laboratory 
sleep study; therefore, we suggest you discuss these results with your primary 
physician for further evaluation.  You should expect a phone call from us within 
the next two weeks to answer any questions you may have.   
 
Thank you for your participation in this study. 
 
Sincerely, 
 
 
Kristin Dillow, RDH 
Master’s Candidate in Dental Hygiene Education 
University of North Carolina at Chapel Hill 
School of Dentistry 
kdillow@dentistry.unc.edu 
919-720-6594 
	
38 
 
REFERENCES 
 
1. Peppard PE, Young T, Barnet JH, Palta M, Hagen EW, Hia KM. Increased prevalence of 
sleep-disordered breathing in adults. Am J Epidemiol 2013 doi: 10.1093/aje/kws342. 
 
2. Barsh L. The recognition and management of sleep-breathing disorders: a mandate for 
dentistry. Sleep Breath 2009;13(1):1-2. 
 
3. Young T, Evans L, Finn L, Palta M. Estimation of the clinically diagnosed proportion of 
sleep apnea syndrome in middle-aged me and women. Sleep 1997;20(9):705-6. 
 
4. Young P, Peppard TE, Taheri S. Excess weight and sleep disordered breathing. J Appl 
Physiol 2005;99(4):1592-9. 
 
5. Ohayon MM, Guilleminault C, Priest RG, Zulley J, Smime S. Is sleep-disordered 
breathing an independent risk factor for hypertension in the general population? J 
Psychosom Res 2000;48(6):593-601. 
 
6. Somers VK, White DP, Amin R, et al. Sleep apnea and cardiovascular disease: expert 
consensus document. J Am Coll Cardiol 2008;52(8):686-717. 
 
7. Punjabi NM, Sorkin JD, Katzel LI, Goldberg AP, Schwartz AR, Smith PL. Sleep 
disordered breathing and insulin resistance in middle-aged and overweight men. Am J 
Respir Crit Care Med 2002;165(5):677-82. 
 
8. Yaggi HK, Concato J, Kernan WN, Lichtman JH, Brass LM, Mohsenin V. Obstructive 
sleep apnea as a risk factor for stroke and death. N Engl J Med 2005;353(19):2034-41. 
 
9. Peppard PE, Szklo-Coxe M, Hla KM, Young T. Longitudinal association of sleep-related 
breathing disorder and depression. Arch Intern Med 2006;166(16):1709-15. 
 
10. Abrishami A, Khajehdehi A, Chung F. A systematic review of screening questionnaires 
for obstructive sleep apnea. Can J Anesth/J Can Anesth 2010;57(5):423-38. 
 
11. Barak-Shinar D, Amos Y, Bogan RK. Sleep disordered breathing analysis in a general 
population using standard pulse oximeter signals. Sleep Breath 2013;17(3):1109-15. 
 
12. Chen H, Lowe AA, Bai Y, Hamilton P, Fleetham JA, Almeida FR. Evaluation of a 
portable recording device (ApneaLink) for case selection of obstructive sleep apnea. 
Sleep Breath 2009; 13(3):213-9. 
13. Polese JF, Santos-Silva R, de Oliveira Ferrari PM, Sartori DE, Tufik S, Bittencourt L. Is 
portable monitoring for diagnosing obstructive sleep apnea syndrome suitable in elderly 
population? Sleep Breath 2013;17(2):679-86. 
 
14. Ahmad N, Sanders AE, Sheats R, Brame J, Essick GK. Obstructive Sleep Apnea in 
Association with Periodontitis. J Dent Hyg 2013;87(4):188-99. 
39 
 
 
15. Gunaratnam K, Taylor B, Curtis B, Cistulli P. Obstructive sleep apnoea and periodontitis: 
a novel association? Sleep Breath 2009;13(3)233-9. 
 
16. Levendowski DJ, Morgan T, Montague J, Melzer V, Berka C, Westbrook PR. Prevalence 
of probable sleep apnea risk and severity in a population of dental patients. Sleep Breath 
2009;13(3):299-300. 
 
17. Strauss SM, Alfano MC, Shelley D, Fulmer T. Identifying unaddressed systemic health 
conditions at dental visits: patients who visited dental practices but not general health 
care providers in 2008. Am J Pub Health 2012;102(2):253-5.   
 
18. Flemons WW, McNicholas WT. Clinical prediction of the sleep apnea syndrome. Sleep 
Med Rev 1997;1(1):19-32. 
 
19. Mehta V, Subramanyam R, Shapiro C, Chung F.  Health effects of identifying patients 
with undiagnosed obstructive sleep apnea in the preoperative clinic: a follow-up study. 
Can J Anaesth 2012;59(6):544-55. 
 
20. Bradley TD, Phillipson EA. Central sleep apnea. Clin Chest Med 1992;13:493-505. 
 
21. Young T, Peppard PE, Gottlieb DJ. Epidemiology of obstructive sleep apnea: a 
population health perspective. Am J Respir Crit Care Med 2002;165(9):1217-39. 
 
22. Institute for Clinical Systems Improvement 2008. Accessed 12 March 2014. 
<https://www.icsi.org/> 
 
23. National Institute for Health and Care Excellence 2010. Accessed 12 March 2014. 
<http://www.nice.org.uk/> 
 
24. Chung F, Yegneswaran B, Liao P, et al. STOP questionnaire: a tool to screen patients for 
obstructive sleep apnea. Anesthesiology 2008;108(5):812-21. 
 
25. Gottlieb DJ, Whitney CW, Bonekat WH, et al. Relation of sleepiness to respiratory 
disturbance index: the Sleep Heart Health Study. Am J Respir Crit Care Med 
1999;159(2):502-7. 
 
26. Niijima K, Enta K, Hori H, et al. The Usefulness of Sleep Apnea Screening using a 
Portable Pulse Oximeter in the Workplace. J Occup Health 2007;49(1):1-8. 
27. Cooper BG, Veale D, Griffiths CJ, et al. Value of nocturnal oxygen saturation as a 
screening test for sleep apnoea. Thorax 1991;46(8);586-8. 
 
28. Netzer N, Eliasson AH, Netzer C, Kristo DA. Overnight pulse oximetry for sleep-
disordered breathing in adults: a review. Chest 2001;120(2):625-33. 
 
40 
 
29. Nuber R, Varvrina J, Karrer W. Predictive value of nocturnal pulse oximetry in sleep 
apnea screening. Schweiz Med Wochenschr Supp 2000;116:120S-122S.  
 
30. Oeverland B, Skatvedt O, et al. Pulseoximetry: sufficient to diagnose severe sleep apnea.  
Sleep Med 2002;3(2):133-8. 
 
31. Nigro CA, Aimaretti S, Gonzalez S, Rhodius E. Validation of the WristOx 3100TM 
oximeter for the diagnosis of sleep apnea/hypopnea syndrome. Sleep Breath 
2009;13(2):127-36. 
 
32. Gyulay S, Olson LG, Hensley MJ, et al. A comparison of clinical assessment and home 
oximetry in the diagnosis of obstructive sleep apnea. Am Rev Respir Dis 1993;147(1):50-
3. 
 
33. Barsh LI. Responsibilities of the dental profession in the recognition and treatment of 
sleep breathing disorders. Sleep Breath 1997;2(2):41-4. 
 
34. Creanor S, Millward BA, Demaine A, Price L, Smith W, Brown N, Creanor SL. Patients’ 
attitudes towards screening for diabetes and other medical conditions in the dental 
setting. Br Dent J 2014;216(1). 
 
35. Engstrom S, Berne C, Gahnberg L, Svardsudd K. Efficacy of screening for high blood 
pressure in dental health care. BMC Public Health 2011;11:194. 
 
36. Healthy People 2013. U.S. Department of Health and Human Services. Accessed 12 
March 2014. <http://www.healthypeople.gov> 
 
37. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-
disordered breathing among middle-aged adults. N Engl J Med 1993;328(17):1230-5.  
 
38. Dancey DR, Hanly PJ, Soong C, Lee B, Shepard J Jr, Hoffstein V. Gender differences in 
sleep apnea: the role of neck circumference. Chest 2003;123(5):1544-50. 
 
39. Millman RP, Carlisle CC, McGarvey ST, Eveloff SE, Levinson PD. Body fat distribution 
and sleep apnea severity in women. Chest 1995;107(2):362-6. 
 
 
40. O'Connor C, Thornley KS, Hanly PJ. Gender differences in the polysomnographic 
features of obstructive sleep apnea. Am J Respir Crit Care Med 2000;161(5):1465-72. 
 
41. Olson AL, Zwillich C. The obesity hypoventilation syndrome. Am J Med 
2005;118(9):948-56. 
 
42. Gordis L. Epidemiology 4th ed. Philadelphia, PA: Saunders Elsevier; 2009. 91-6 p. 
 
41 
 
43. Iglesias C, Torgerson D. Does length of questionnaire matter? A randomised trial of 
response rates to a mailed questionnaire. J Health Serv Res Policy 2000;5(4):219-21. 
 
44. Nasseh K, Greenberg B, Vujicic M, Glick M. The effect of chairside chronic disease 
screenings by oral health professionals on health care costs. Am J Public Health 
2014;104(4):744-50. 
 
 
 
 
 
 
 
 
